Present and future perspectives on the use of free or encapsulated pancreatic islet cell transplantation as a treatment of pregnancy complicated by type 1 diabetes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 9, Issue 1, 2000, Pages 46-51

  Hunter, Stephen K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Diabetes; Islet cells; Pregnancy; Transplantation

Indexed keywords

ARTICLE; CELL TRANSPLANTATION; CONGENITAL MALFORMATION; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; PREGNANCY; PREGNANCY IN DIABETICS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034025360     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Miller E, Hare JW, Cloherty JP, Dun, PJ, Gleason RE, Soeldner JS, Kitzmiller JL. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331-1334.
2. Simpson JL, Elias S, Mattin AO, Palmer MS, Ogata ES, Radvany RA. Diabetes in pregnancy. Northwestern University series (1977-1981). Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 1983;146:263-270.
3. Albert TJ, Landon MB, Wheller JJ, Samuals P, Cheng RF, Gabbe S. Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1996;174: 1424-1428.
4. Perinatal mortality and congenital malformations in infants born to women with insulin-dependent diabetes mellitus - United States, Canada, and Europe. 1940-1988. MMWR Morb Mort Wkly Rep 1990;39:363-365.
5. Eriksson UJ. The pathogenesis of congenital malformations in diabetic pregnancy. Diabetes Metab Rev 1995;11:63-82.
6. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983;6:219-223.
7. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with pre-conceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986;155:293-297.
8. Baker L, Egler JM, Klein SH, Goldman AS. Meticulous control of diabetes during organogenesis in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 1981;30:955-959.
9. Barrou B, Vidart A, Bitker MO, Ourahma S, Mouquet C, Luciani J, Grimaldi A, Lefevre G, Chatelain C. Pregnancy after pancreas transplantation: report of a new case. Transplant Proc 1995;27:1757.
10. Barrou B, Baldi A, Bitker MO, Squifflet JP, Gruessner RW, Sutherland DER. Pregnancy after pancreas transplantation: report of four new cases and review of the literature. Transplant Proc 1995;27:3043.
11. Moudry-Munns KC, Barrou B, Sutherland DER. Pregnancy after pancreas transplantation: report from the International Pancreas Transplant Registry. Transplant Proc 1996;28:3639.
12. Barrou B, Gruessner AC, Sutherland DER, Gruessner RWG. Pregnancy after pancreas transplantation in the cyclosporine era. Tranplantation 1998;65:524-527.
13. McGrory CH, Groshek MA, Sollinger HW, Moritz MJ, Armenti VT. Pregnancy outcomes in female pancreas-kidney recipients. Transplant Proc 1999;31:652-653.
14. Kenyon NS, Ranuncoli A, Masetti M, Chatzipetrou M, Ricordi C. Islet transplantation: present and future perspectives. Diabetes Metab Rev 1998;14:303-313.
15. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas and nondiabetic kidney transplant recipients. Diabetes 1994:43:593-598.
16. Mandel TE, Koulmanda M, Kovarik J, Georgiou HM, Francis DMA, Dawson P, Stainsby G. Transplantation of organ cultured fetal pig pancreas in non-obese diabetic (NOD) mice and primates (Macaca fascicularis). Xenotransplantation 1995;2:128-132.
17. Mandel TE, Koulmanda M, Cozzi E, Waterworth P, Tolan M, Langford B, White DJ. Transplantation of normal and DAF-transgenic fetal pig pancreas into cynomolgus monkeys. Transplant Proc 1997;29:940.
18. Groth CG, Korsgren O, Tibell A, Tolleman J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom L, Anderson A. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344:1402-1404.
19. Pierson RN 3d, Winn HJ, Russell PS, Auchincloss H Jr. Xenogenic skin graft rejection is especially dependent by CD4+T-cells. J Exp Med 1989;170:991-996.
20. Mandel TE, Kovaric J, Koulmanda M. A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immune suppressed non-obese diabetic mice. Am J Pathol 1995;147:834-844.
21. Sutherland DE, Goetz FC, Sibley RK. Recurrence in disease in pancreas transplants. Diabetes 1989;39:85-87.
22. Bretzel RG, Hering BJ, Brendel MD, Schultz AO, Schultz B, Vietzke R. Insulin independence following islet transplantation in man: a comparison of different recipient catagories. Int Islet Transplant Registry Newsletter December 1996;7.
23. Wahoff DC, Leone JP, Farney AC, Teuscher AU, Sutherland DER. Pregnancy after total pancreatectomy and autologous islet transplantation. Surgery 1995;117:353-354.
24. Ferber S, Heimberg H, Colton C. Surrogate beta cells. Diabetologia 1997;40:B39-B43.
25. Desai NM, Korbutt GS, Barker CF, Lafferty KJ. Beta-cell replacement. Diabetlogia 1997;40:B44-B49.
26. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990;249:1293-1295.
27. Lenschow DJ, Zeng Y, Thistlewhaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA. Long-term survival of xenogenic pancreatic islet grafts induced by CTLA4Ig. Science 1992;257:789-792.
28. Steurer W, Nickerson PW, Steele AW, Steiger, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995;155:1165-1174.
29. Weber CJ, Hagler M, Safley S, Linsley P, Kapp J. Diabetic NOD mouse immunoreactivity toward microencapsulated neonatal porcine islet xenografts (abstract). Acta Diabetol 1997;34:103.
30. Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 1995;59:1313-1318.
31. Korbutt GS, Elliot JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997;46:317-322.
32. Selawry HP, Cameron DF. Sertolic cell-enriched fractions in successful islet cell transplantation. Cell Transplant 1993;2:123-129.
33. Soon-Shiong P, Heintz RE, Meridith N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Sandford PA. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994;343:950-951.
34. Soon-Shiong P. Treatment of type I diabetes using encapsulated islets. Adv Drug Deliv Rev 1999;35:259-270.
35. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 1992;130:1459-1466.
36. Hunter SK, Wang Y, Weiner CP, Niebyl J. Encapsulated β-islet cells as a bioartificial pancreas to treat insulin-dependent diabetes during pregnancy. Am J Obstet Gynecol 1997;177:746-752.
37. Hunter SK, Wang Y, Rodgers VGJ. Bioartificial pancreas use in diabetic pregnancy. ASAIO J 1999.
38. Hunter SK, Kao JM, Wang Y, Benda J, Rodgers VGJ. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances. ASAIO J 1999.